Cargando…
Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: A population‐based cohort study in older adults
The selective serotonin reuptake inhibitors (SSRIs) citalopram and escitalopram are associated with QT prolongation, which increases the risk of serious arrhythmia. Consequently, regulatory agencies issued safety warnings in 2011. This study aimed to investigate the risk of serious arrhythmia follow...
Autores principales: | Aakjær, Mia, Werther, Sarah Kimmer, De Bruin, Marie Louise, Andersen, Morten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468567/ https://www.ncbi.nlm.nih.gov/pubmed/35733364 http://dx.doi.org/10.1111/cts.13319 |
Ejemplares similares
-
Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
por: Gjestad, Caroline, et al.
Publicado: (2015) -
Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study
por: Qirjazi, Elena, et al.
Publicado: (2016) -
Prediction of Ventricular Arrhythmias by QRS/QTc - Ratio in Citalopram or Escitalopram Intoxication
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2022) -
Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data
por: Aakjær, Mia, et al.
Publicado: (2021) -
Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)